Ribomic Inc. (TYO: 4591)

Japan flag Japan · Delayed Price · Currency is JPY
84.00
+1.00 (1.20%)
Sep 27, 2024, 11:05 AM JST
-38.69%
Market Cap 3.18B
Revenue (ttm) 1.00M
Net Income (ttm) -944.00M
Shares Out 38.29M
EPS (ttm) -26.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 146,600
Open 83.00
Previous Close 83.00
Day's Range 83.00 - 85.00
52-Week Range 60.00 - 140.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 11, 2024

About Ribomic

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 24
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4591
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.